%0 Journal Article
%T MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
%A Fell, Matthew J.
%A Mirescu, Christian
%A Basu, Kallol
%A Cheewatrakoolpong, Boonlert
%A DeMong, Duane E.
%A Ellis, J. Michael
%A Hyde, Lynn A.
%A Lin, Yinghui
%A Markgraf, Carrie G.
%A Mei, Hong
%A Miller, Michael
%A Poulet, Frederique M.
%A Scott, Jack D.
%A Smith, Michelle D.
%A Yin, Zhizhang
%A Zhou, Xiaoping
%A Parker, Eric M.
%A Kennedy, Matthew E.
%A Morrow, John A.
%A ,
%J The Journal of Pharmacology and Experimental Therapeutics
%@ 0022-3565
%D 2015-09-25
%I American Society for Pharmacology & Experimental Therapeutics (ASPET)
%~ DeepDyve